AuraVax Therapeutics, Inc., a company developing novel immunotherapies to prevent and treat respiratory pathogens, today ...

AuraVax collaborates with Codagenix Inc. to demonstrate NanoSTING-002 with intranasal live-attenuated vaccines ... as a candidate for a pandemic influenza vaccine. The two companies will test ...

The isolation of influenza virus 80 years ago in 1933 very quickly led to the development of the first generation of live-attenuated vaccines. The first inactivated influenza vaccine was ...

The global sales of attenuated vaccines are projected to soar, with an estimated worth of USD 5,068.2 million in 2024 and anticipated to reach USD 9,693.9 million by 2034. This growth trajectory ...

Influenza A is the most common variant of the flu and the one you’re most likely to get during pregnancy. A flu shot is the ...

Initial data from clinical trials evaluating H5N1/H5N2 live-attenuated influenza vaccine suggest that immunization of unprimed subjects is not associated with a serologic response that is markedly ...

Aug. 15, 2024 — A unique influenza vaccine candidate that's inhaled ... vaccine with nasal spray administration of a novel attenuated live flu virus appears to be safe and ...

a pneumococcal conjugate vaccine, and a live attenuated influenza vaccine. As a Senior Vice President at Wyeth Pharmaceuticals, Bruce was responsible for all late phase development activities in Wyeth ...

That's true for influenza vaccine ... particularly for a live attenuated (weakened) vaccine, which would yield better immunity. BPZE1 is such a nasally administered live vaccine in development.

It’s recommended that pregnant women get the flu shot—either the inactivated or recombinant vaccine—rather than the live ...